single-cell rna-sequencing data-preprocessing methods Search Results


86
10X Genomics chromium single cell 5 reagent kit
Chromium Single Cell 5 Reagent Kit, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chromium single cell 5 reagent kit/product/10X Genomics
Average 86 stars, based on 1 article reviews
chromium single cell 5 reagent kit - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

90
Regeneron inc single-cell rna-sequencing data-preprocessing methods
Single Cell Rna Sequencing Data Preprocessing Methods, supplied by Regeneron inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/single-cell rna-sequencing data-preprocessing methods/product/Regeneron inc
Average 90 stars, based on 1 article reviews
single-cell rna-sequencing data-preprocessing methods - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

86
10X Genomics cell suspension
Cell Suspension, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell suspension/product/10X Genomics
Average 86 stars, based on 1 article reviews
cell suspension - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
10X Genomics 10x chromium single cell instrument
10x Chromium Single Cell Instrument, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/10x chromium single cell instrument/product/10X Genomics
Average 86 stars, based on 1 article reviews
10x chromium single cell instrument - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

90
SomaLogic high-content proteomics somalogic
a . Clinical case study 1: Classification of individuals with normotensive pregnancy or preeclampsia (PE) from the analysis of circulating cell-free <t>RNA</t> (cfRNA) <t>sequencing</t> data. Number of samples (n) and features (p) are indicated. b. UMAP visualization of the cfRNA transcriptomic features, node size and color are proportional to the strength of the association with the outcome calculated as the p-value in a univariate Mann-Whitney test using a −log10 scale. c . Clinical case study 2: Classification of mild vs. severe COVID-19 in two independent patient cohorts from the analysis of plasma proteomic data (Olink). d. UMAP visualization of the proteomic data. Node characteristics as in ( b ). e. Predictivity performances of Stabl and Lasso for the PE datasets. AUROC Stabl = 0.83 [0.76, 0.90] , AUROC Lasso = 0.84 [0.78, 0.90] (p-value = 0.28, Bootstrap test); AUPRC Stabl = 0.85 [0.77, 0.93] , AUPRC Lasso = 0.89 [0.83, 0.94] (p-value = 0.18) f. AUROC comparing predictive performance of Stabl and Lasso on training (left panel) and validation (right panel) cohorts for the COVID-19 dataset. Training: AUROC Stabl = 0.85 [0.74, 0.94] , AUROC Lasso = 0.86 [0.75, 0.94] (p-value = 0.37) . Validation: AUROC Stabl = 0.75 [0.71, 0.79] , AUROC Lasso = 0.76 [0.71, 0.81] (p-value = 0.44) . AUPRC are shown in Fig. S12. g-h. Left panels. Sparsity performances for the PE ( g , number of features selected across cross-validation iterations, median Stabl = 11.0, IQR = [7.8,16.0], median Lasso = 225.5, IQR = [147.5,337.5], p-value < 1e-16 ) and COVID-19 ( h, median Stabl = 7.0, IQR = [4.8,13.0], median Lasso = 19.0, IQR = [8.0,100.0], p-value = 4e-10) datasets. Right panels. Stability path graphs showing the regularization parameter against the selection frequency. The reliability threshold ( θ ), is indicated (dotted line) i-k . Volcano plots depicting the reliability performances of Stabl and Lasso for the PE ( i ), COVID-19 training ( j ) and COVID-19 validation ( k ) datasets. The maximum frequency of selection of each feature is plotted against the −log10 p-value using a univariate Mann-Whitney test. Features selected by Stabl/Lasso only are colored in red/black respectively. Features selected by Stabl are labeled. PE: mean − log10(p-value) Stabl = 8.2; mean − log10(p-value) Lasso = 3.3 . COVID-19 training: mean − log10(p-value) Stabl = 5.5; mean − log10(p - value) Lasso = 5.2 . COVID-19 validation: mean − log(p-value) Stabl = 9.7; mean − log10(p-value) Lasso = 7.8 . Benchmarking of Stabl against elastic net (EN) is shown in Fig. S11 .
High Content Proteomics Somalogic, supplied by SomaLogic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/high-content proteomics somalogic/product/SomaLogic
Average 90 stars, based on 1 article reviews
high-content proteomics somalogic - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

86
10X Genomics chromium single cell 3
a . Clinical case study 1: Classification of individuals with normotensive pregnancy or preeclampsia (PE) from the analysis of circulating cell-free <t>RNA</t> (cfRNA) <t>sequencing</t> data. Number of samples (n) and features (p) are indicated. b. UMAP visualization of the cfRNA transcriptomic features, node size and color are proportional to the strength of the association with the outcome calculated as the p-value in a univariate Mann-Whitney test using a −log10 scale. c . Clinical case study 2: Classification of mild vs. severe COVID-19 in two independent patient cohorts from the analysis of plasma proteomic data (Olink). d. UMAP visualization of the proteomic data. Node characteristics as in ( b ). e. Predictivity performances of Stabl and Lasso for the PE datasets. AUROC Stabl = 0.83 [0.76, 0.90] , AUROC Lasso = 0.84 [0.78, 0.90] (p-value = 0.28, Bootstrap test); AUPRC Stabl = 0.85 [0.77, 0.93] , AUPRC Lasso = 0.89 [0.83, 0.94] (p-value = 0.18) f. AUROC comparing predictive performance of Stabl and Lasso on training (left panel) and validation (right panel) cohorts for the COVID-19 dataset. Training: AUROC Stabl = 0.85 [0.74, 0.94] , AUROC Lasso = 0.86 [0.75, 0.94] (p-value = 0.37) . Validation: AUROC Stabl = 0.75 [0.71, 0.79] , AUROC Lasso = 0.76 [0.71, 0.81] (p-value = 0.44) . AUPRC are shown in Fig. S12. g-h. Left panels. Sparsity performances for the PE ( g , number of features selected across cross-validation iterations, median Stabl = 11.0, IQR = [7.8,16.0], median Lasso = 225.5, IQR = [147.5,337.5], p-value < 1e-16 ) and COVID-19 ( h, median Stabl = 7.0, IQR = [4.8,13.0], median Lasso = 19.0, IQR = [8.0,100.0], p-value = 4e-10) datasets. Right panels. Stability path graphs showing the regularization parameter against the selection frequency. The reliability threshold ( θ ), is indicated (dotted line) i-k . Volcano plots depicting the reliability performances of Stabl and Lasso for the PE ( i ), COVID-19 training ( j ) and COVID-19 validation ( k ) datasets. The maximum frequency of selection of each feature is plotted against the −log10 p-value using a univariate Mann-Whitney test. Features selected by Stabl/Lasso only are colored in red/black respectively. Features selected by Stabl are labeled. PE: mean − log10(p-value) Stabl = 8.2; mean − log10(p-value) Lasso = 3.3 . COVID-19 training: mean − log10(p-value) Stabl = 5.5; mean − log10(p - value) Lasso = 5.2 . COVID-19 validation: mean − log(p-value) Stabl = 9.7; mean − log10(p-value) Lasso = 7.8 . Benchmarking of Stabl against elastic net (EN) is shown in Fig. S11 .
Chromium Single Cell 3, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chromium single cell 3/product/10X Genomics
Average 86 stars, based on 1 article reviews
chromium single cell 3 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
10X Genomics updated cell ranger version
a . Clinical case study 1: Classification of individuals with normotensive pregnancy or preeclampsia (PE) from the analysis of circulating cell-free <t>RNA</t> (cfRNA) <t>sequencing</t> data. Number of samples (n) and features (p) are indicated. b. UMAP visualization of the cfRNA transcriptomic features, node size and color are proportional to the strength of the association with the outcome calculated as the p-value in a univariate Mann-Whitney test using a −log10 scale. c . Clinical case study 2: Classification of mild vs. severe COVID-19 in two independent patient cohorts from the analysis of plasma proteomic data (Olink). d. UMAP visualization of the proteomic data. Node characteristics as in ( b ). e. Predictivity performances of Stabl and Lasso for the PE datasets. AUROC Stabl = 0.83 [0.76, 0.90] , AUROC Lasso = 0.84 [0.78, 0.90] (p-value = 0.28, Bootstrap test); AUPRC Stabl = 0.85 [0.77, 0.93] , AUPRC Lasso = 0.89 [0.83, 0.94] (p-value = 0.18) f. AUROC comparing predictive performance of Stabl and Lasso on training (left panel) and validation (right panel) cohorts for the COVID-19 dataset. Training: AUROC Stabl = 0.85 [0.74, 0.94] , AUROC Lasso = 0.86 [0.75, 0.94] (p-value = 0.37) . Validation: AUROC Stabl = 0.75 [0.71, 0.79] , AUROC Lasso = 0.76 [0.71, 0.81] (p-value = 0.44) . AUPRC are shown in Fig. S12. g-h. Left panels. Sparsity performances for the PE ( g , number of features selected across cross-validation iterations, median Stabl = 11.0, IQR = [7.8,16.0], median Lasso = 225.5, IQR = [147.5,337.5], p-value < 1e-16 ) and COVID-19 ( h, median Stabl = 7.0, IQR = [4.8,13.0], median Lasso = 19.0, IQR = [8.0,100.0], p-value = 4e-10) datasets. Right panels. Stability path graphs showing the regularization parameter against the selection frequency. The reliability threshold ( θ ), is indicated (dotted line) i-k . Volcano plots depicting the reliability performances of Stabl and Lasso for the PE ( i ), COVID-19 training ( j ) and COVID-19 validation ( k ) datasets. The maximum frequency of selection of each feature is plotted against the −log10 p-value using a univariate Mann-Whitney test. Features selected by Stabl/Lasso only are colored in red/black respectively. Features selected by Stabl are labeled. PE: mean − log10(p-value) Stabl = 8.2; mean − log10(p-value) Lasso = 3.3 . COVID-19 training: mean − log10(p-value) Stabl = 5.5; mean − log10(p - value) Lasso = 5.2 . COVID-19 validation: mean − log(p-value) Stabl = 9.7; mean − log10(p-value) Lasso = 7.8 . Benchmarking of Stabl against elastic net (EN) is shown in Fig. S11 .
Updated Cell Ranger Version, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/updated cell ranger version/product/10X Genomics
Average 86 stars, based on 1 article reviews
updated cell ranger version - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

98
Illumina Inc hiseq 4000
a . Clinical case study 1: Classification of individuals with normotensive pregnancy or preeclampsia (PE) from the analysis of circulating cell-free <t>RNA</t> (cfRNA) <t>sequencing</t> data. Number of samples (n) and features (p) are indicated. b. UMAP visualization of the cfRNA transcriptomic features, node size and color are proportional to the strength of the association with the outcome calculated as the p-value in a univariate Mann-Whitney test using a −log10 scale. c . Clinical case study 2: Classification of mild vs. severe COVID-19 in two independent patient cohorts from the analysis of plasma proteomic data (Olink). d. UMAP visualization of the proteomic data. Node characteristics as in ( b ). e. Predictivity performances of Stabl and Lasso for the PE datasets. AUROC Stabl = 0.83 [0.76, 0.90] , AUROC Lasso = 0.84 [0.78, 0.90] (p-value = 0.28, Bootstrap test); AUPRC Stabl = 0.85 [0.77, 0.93] , AUPRC Lasso = 0.89 [0.83, 0.94] (p-value = 0.18) f. AUROC comparing predictive performance of Stabl and Lasso on training (left panel) and validation (right panel) cohorts for the COVID-19 dataset. Training: AUROC Stabl = 0.85 [0.74, 0.94] , AUROC Lasso = 0.86 [0.75, 0.94] (p-value = 0.37) . Validation: AUROC Stabl = 0.75 [0.71, 0.79] , AUROC Lasso = 0.76 [0.71, 0.81] (p-value = 0.44) . AUPRC are shown in Fig. S12. g-h. Left panels. Sparsity performances for the PE ( g , number of features selected across cross-validation iterations, median Stabl = 11.0, IQR = [7.8,16.0], median Lasso = 225.5, IQR = [147.5,337.5], p-value < 1e-16 ) and COVID-19 ( h, median Stabl = 7.0, IQR = [4.8,13.0], median Lasso = 19.0, IQR = [8.0,100.0], p-value = 4e-10) datasets. Right panels. Stability path graphs showing the regularization parameter against the selection frequency. The reliability threshold ( θ ), is indicated (dotted line) i-k . Volcano plots depicting the reliability performances of Stabl and Lasso for the PE ( i ), COVID-19 training ( j ) and COVID-19 validation ( k ) datasets. The maximum frequency of selection of each feature is plotted against the −log10 p-value using a univariate Mann-Whitney test. Features selected by Stabl/Lasso only are colored in red/black respectively. Features selected by Stabl are labeled. PE: mean − log10(p-value) Stabl = 8.2; mean − log10(p-value) Lasso = 3.3 . COVID-19 training: mean − log10(p-value) Stabl = 5.5; mean − log10(p - value) Lasso = 5.2 . COVID-19 validation: mean − log(p-value) Stabl = 9.7; mean − log10(p-value) Lasso = 7.8 . Benchmarking of Stabl against elastic net (EN) is shown in Fig. S11 .
Hiseq 4000, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hiseq 4000/product/Illumina Inc
Average 98 stars, based on 1 article reviews
hiseq 4000 - by Bioz Stars, 2026-06
98/100 stars
  Buy from Supplier

86
Denovo Biotechnology genomics cell ranger software v3 1 0
a . Clinical case study 1: Classification of individuals with normotensive pregnancy or preeclampsia (PE) from the analysis of circulating cell-free <t>RNA</t> (cfRNA) <t>sequencing</t> data. Number of samples (n) and features (p) are indicated. b. UMAP visualization of the cfRNA transcriptomic features, node size and color are proportional to the strength of the association with the outcome calculated as the p-value in a univariate Mann-Whitney test using a −log10 scale. c . Clinical case study 2: Classification of mild vs. severe COVID-19 in two independent patient cohorts from the analysis of plasma proteomic data (Olink). d. UMAP visualization of the proteomic data. Node characteristics as in ( b ). e. Predictivity performances of Stabl and Lasso for the PE datasets. AUROC Stabl = 0.83 [0.76, 0.90] , AUROC Lasso = 0.84 [0.78, 0.90] (p-value = 0.28, Bootstrap test); AUPRC Stabl = 0.85 [0.77, 0.93] , AUPRC Lasso = 0.89 [0.83, 0.94] (p-value = 0.18) f. AUROC comparing predictive performance of Stabl and Lasso on training (left panel) and validation (right panel) cohorts for the COVID-19 dataset. Training: AUROC Stabl = 0.85 [0.74, 0.94] , AUROC Lasso = 0.86 [0.75, 0.94] (p-value = 0.37) . Validation: AUROC Stabl = 0.75 [0.71, 0.79] , AUROC Lasso = 0.76 [0.71, 0.81] (p-value = 0.44) . AUPRC are shown in Fig. S12. g-h. Left panels. Sparsity performances for the PE ( g , number of features selected across cross-validation iterations, median Stabl = 11.0, IQR = [7.8,16.0], median Lasso = 225.5, IQR = [147.5,337.5], p-value < 1e-16 ) and COVID-19 ( h, median Stabl = 7.0, IQR = [4.8,13.0], median Lasso = 19.0, IQR = [8.0,100.0], p-value = 4e-10) datasets. Right panels. Stability path graphs showing the regularization parameter against the selection frequency. The reliability threshold ( θ ), is indicated (dotted line) i-k . Volcano plots depicting the reliability performances of Stabl and Lasso for the PE ( i ), COVID-19 training ( j ) and COVID-19 validation ( k ) datasets. The maximum frequency of selection of each feature is plotted against the −log10 p-value using a univariate Mann-Whitney test. Features selected by Stabl/Lasso only are colored in red/black respectively. Features selected by Stabl are labeled. PE: mean − log10(p-value) Stabl = 8.2; mean − log10(p-value) Lasso = 3.3 . COVID-19 training: mean − log10(p-value) Stabl = 5.5; mean − log10(p - value) Lasso = 5.2 . COVID-19 validation: mean − log(p-value) Stabl = 9.7; mean − log10(p-value) Lasso = 7.8 . Benchmarking of Stabl against elastic net (EN) is shown in Fig. S11 .
Genomics Cell Ranger Software V3 1 0, supplied by Denovo Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genomics cell ranger software v3 1 0/product/Denovo Biotechnology
Average 86 stars, based on 1 article reviews
genomics cell ranger software v3 1 0 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
10X Genomics rna sequencing
a . Clinical case study 1: Classification of individuals with normotensive pregnancy or preeclampsia (PE) from the analysis of circulating cell-free <t>RNA</t> (cfRNA) <t>sequencing</t> data. Number of samples (n) and features (p) are indicated. b. UMAP visualization of the cfRNA transcriptomic features, node size and color are proportional to the strength of the association with the outcome calculated as the p-value in a univariate Mann-Whitney test using a −log10 scale. c . Clinical case study 2: Classification of mild vs. severe COVID-19 in two independent patient cohorts from the analysis of plasma proteomic data (Olink). d. UMAP visualization of the proteomic data. Node characteristics as in ( b ). e. Predictivity performances of Stabl and Lasso for the PE datasets. AUROC Stabl = 0.83 [0.76, 0.90] , AUROC Lasso = 0.84 [0.78, 0.90] (p-value = 0.28, Bootstrap test); AUPRC Stabl = 0.85 [0.77, 0.93] , AUPRC Lasso = 0.89 [0.83, 0.94] (p-value = 0.18) f. AUROC comparing predictive performance of Stabl and Lasso on training (left panel) and validation (right panel) cohorts for the COVID-19 dataset. Training: AUROC Stabl = 0.85 [0.74, 0.94] , AUROC Lasso = 0.86 [0.75, 0.94] (p-value = 0.37) . Validation: AUROC Stabl = 0.75 [0.71, 0.79] , AUROC Lasso = 0.76 [0.71, 0.81] (p-value = 0.44) . AUPRC are shown in Fig. S12. g-h. Left panels. Sparsity performances for the PE ( g , number of features selected across cross-validation iterations, median Stabl = 11.0, IQR = [7.8,16.0], median Lasso = 225.5, IQR = [147.5,337.5], p-value < 1e-16 ) and COVID-19 ( h, median Stabl = 7.0, IQR = [4.8,13.0], median Lasso = 19.0, IQR = [8.0,100.0], p-value = 4e-10) datasets. Right panels. Stability path graphs showing the regularization parameter against the selection frequency. The reliability threshold ( θ ), is indicated (dotted line) i-k . Volcano plots depicting the reliability performances of Stabl and Lasso for the PE ( i ), COVID-19 training ( j ) and COVID-19 validation ( k ) datasets. The maximum frequency of selection of each feature is plotted against the −log10 p-value using a univariate Mann-Whitney test. Features selected by Stabl/Lasso only are colored in red/black respectively. Features selected by Stabl are labeled. PE: mean − log10(p-value) Stabl = 8.2; mean − log10(p-value) Lasso = 3.3 . COVID-19 training: mean − log10(p-value) Stabl = 5.5; mean − log10(p - value) Lasso = 5.2 . COVID-19 validation: mean − log(p-value) Stabl = 9.7; mean − log10(p-value) Lasso = 7.8 . Benchmarking of Stabl against elastic net (EN) is shown in Fig. S11 .
Rna Sequencing, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rna sequencing/product/10X Genomics
Average 86 stars, based on 1 article reviews
rna sequencing - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
10X Genomics cellranger count function
a . Clinical case study 1: Classification of individuals with normotensive pregnancy or preeclampsia (PE) from the analysis of circulating cell-free <t>RNA</t> (cfRNA) <t>sequencing</t> data. Number of samples (n) and features (p) are indicated. b. UMAP visualization of the cfRNA transcriptomic features, node size and color are proportional to the strength of the association with the outcome calculated as the p-value in a univariate Mann-Whitney test using a −log10 scale. c . Clinical case study 2: Classification of mild vs. severe COVID-19 in two independent patient cohorts from the analysis of plasma proteomic data (Olink). d. UMAP visualization of the proteomic data. Node characteristics as in ( b ). e. Predictivity performances of Stabl and Lasso for the PE datasets. AUROC Stabl = 0.83 [0.76, 0.90] , AUROC Lasso = 0.84 [0.78, 0.90] (p-value = 0.28, Bootstrap test); AUPRC Stabl = 0.85 [0.77, 0.93] , AUPRC Lasso = 0.89 [0.83, 0.94] (p-value = 0.18) f. AUROC comparing predictive performance of Stabl and Lasso on training (left panel) and validation (right panel) cohorts for the COVID-19 dataset. Training: AUROC Stabl = 0.85 [0.74, 0.94] , AUROC Lasso = 0.86 [0.75, 0.94] (p-value = 0.37) . Validation: AUROC Stabl = 0.75 [0.71, 0.79] , AUROC Lasso = 0.76 [0.71, 0.81] (p-value = 0.44) . AUPRC are shown in Fig. S12. g-h. Left panels. Sparsity performances for the PE ( g , number of features selected across cross-validation iterations, median Stabl = 11.0, IQR = [7.8,16.0], median Lasso = 225.5, IQR = [147.5,337.5], p-value < 1e-16 ) and COVID-19 ( h, median Stabl = 7.0, IQR = [4.8,13.0], median Lasso = 19.0, IQR = [8.0,100.0], p-value = 4e-10) datasets. Right panels. Stability path graphs showing the regularization parameter against the selection frequency. The reliability threshold ( θ ), is indicated (dotted line) i-k . Volcano plots depicting the reliability performances of Stabl and Lasso for the PE ( i ), COVID-19 training ( j ) and COVID-19 validation ( k ) datasets. The maximum frequency of selection of each feature is plotted against the −log10 p-value using a univariate Mann-Whitney test. Features selected by Stabl/Lasso only are colored in red/black respectively. Features selected by Stabl are labeled. PE: mean − log10(p-value) Stabl = 8.2; mean − log10(p-value) Lasso = 3.3 . COVID-19 training: mean − log10(p-value) Stabl = 5.5; mean − log10(p - value) Lasso = 5.2 . COVID-19 validation: mean − log(p-value) Stabl = 9.7; mean − log10(p-value) Lasso = 7.8 . Benchmarking of Stabl against elastic net (EN) is shown in Fig. S11 .
Cellranger Count Function, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cellranger count function/product/10X Genomics
Average 86 stars, based on 1 article reviews
cellranger count function - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
10X Genomics genomics chromium system
a . Clinical case study 1: Classification of individuals with normotensive pregnancy or preeclampsia (PE) from the analysis of circulating cell-free <t>RNA</t> (cfRNA) <t>sequencing</t> data. Number of samples (n) and features (p) are indicated. b. UMAP visualization of the cfRNA transcriptomic features, node size and color are proportional to the strength of the association with the outcome calculated as the p-value in a univariate Mann-Whitney test using a −log10 scale. c . Clinical case study 2: Classification of mild vs. severe COVID-19 in two independent patient cohorts from the analysis of plasma proteomic data (Olink). d. UMAP visualization of the proteomic data. Node characteristics as in ( b ). e. Predictivity performances of Stabl and Lasso for the PE datasets. AUROC Stabl = 0.83 [0.76, 0.90] , AUROC Lasso = 0.84 [0.78, 0.90] (p-value = 0.28, Bootstrap test); AUPRC Stabl = 0.85 [0.77, 0.93] , AUPRC Lasso = 0.89 [0.83, 0.94] (p-value = 0.18) f. AUROC comparing predictive performance of Stabl and Lasso on training (left panel) and validation (right panel) cohorts for the COVID-19 dataset. Training: AUROC Stabl = 0.85 [0.74, 0.94] , AUROC Lasso = 0.86 [0.75, 0.94] (p-value = 0.37) . Validation: AUROC Stabl = 0.75 [0.71, 0.79] , AUROC Lasso = 0.76 [0.71, 0.81] (p-value = 0.44) . AUPRC are shown in Fig. S12. g-h. Left panels. Sparsity performances for the PE ( g , number of features selected across cross-validation iterations, median Stabl = 11.0, IQR = [7.8,16.0], median Lasso = 225.5, IQR = [147.5,337.5], p-value < 1e-16 ) and COVID-19 ( h, median Stabl = 7.0, IQR = [4.8,13.0], median Lasso = 19.0, IQR = [8.0,100.0], p-value = 4e-10) datasets. Right panels. Stability path graphs showing the regularization parameter against the selection frequency. The reliability threshold ( θ ), is indicated (dotted line) i-k . Volcano plots depicting the reliability performances of Stabl and Lasso for the PE ( i ), COVID-19 training ( j ) and COVID-19 validation ( k ) datasets. The maximum frequency of selection of each feature is plotted against the −log10 p-value using a univariate Mann-Whitney test. Features selected by Stabl/Lasso only are colored in red/black respectively. Features selected by Stabl are labeled. PE: mean − log10(p-value) Stabl = 8.2; mean − log10(p-value) Lasso = 3.3 . COVID-19 training: mean − log10(p-value) Stabl = 5.5; mean − log10(p - value) Lasso = 5.2 . COVID-19 validation: mean − log(p-value) Stabl = 9.7; mean − log10(p-value) Lasso = 7.8 . Benchmarking of Stabl against elastic net (EN) is shown in Fig. S11 .
Genomics Chromium System, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genomics chromium system/product/10X Genomics
Average 86 stars, based on 1 article reviews
genomics chromium system - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

Image Search Results


a . Clinical case study 1: Classification of individuals with normotensive pregnancy or preeclampsia (PE) from the analysis of circulating cell-free RNA (cfRNA) sequencing data. Number of samples (n) and features (p) are indicated. b. UMAP visualization of the cfRNA transcriptomic features, node size and color are proportional to the strength of the association with the outcome calculated as the p-value in a univariate Mann-Whitney test using a −log10 scale. c . Clinical case study 2: Classification of mild vs. severe COVID-19 in two independent patient cohorts from the analysis of plasma proteomic data (Olink). d. UMAP visualization of the proteomic data. Node characteristics as in ( b ). e. Predictivity performances of Stabl and Lasso for the PE datasets. AUROC Stabl = 0.83 [0.76, 0.90] , AUROC Lasso = 0.84 [0.78, 0.90] (p-value = 0.28, Bootstrap test); AUPRC Stabl = 0.85 [0.77, 0.93] , AUPRC Lasso = 0.89 [0.83, 0.94] (p-value = 0.18) f. AUROC comparing predictive performance of Stabl and Lasso on training (left panel) and validation (right panel) cohorts for the COVID-19 dataset. Training: AUROC Stabl = 0.85 [0.74, 0.94] , AUROC Lasso = 0.86 [0.75, 0.94] (p-value = 0.37) . Validation: AUROC Stabl = 0.75 [0.71, 0.79] , AUROC Lasso = 0.76 [0.71, 0.81] (p-value = 0.44) . AUPRC are shown in Fig. S12. g-h. Left panels. Sparsity performances for the PE ( g , number of features selected across cross-validation iterations, median Stabl = 11.0, IQR = [7.8,16.0], median Lasso = 225.5, IQR = [147.5,337.5], p-value < 1e-16 ) and COVID-19 ( h, median Stabl = 7.0, IQR = [4.8,13.0], median Lasso = 19.0, IQR = [8.0,100.0], p-value = 4e-10) datasets. Right panels. Stability path graphs showing the regularization parameter against the selection frequency. The reliability threshold ( θ ), is indicated (dotted line) i-k . Volcano plots depicting the reliability performances of Stabl and Lasso for the PE ( i ), COVID-19 training ( j ) and COVID-19 validation ( k ) datasets. The maximum frequency of selection of each feature is plotted against the −log10 p-value using a univariate Mann-Whitney test. Features selected by Stabl/Lasso only are colored in red/black respectively. Features selected by Stabl are labeled. PE: mean − log10(p-value) Stabl = 8.2; mean − log10(p-value) Lasso = 3.3 . COVID-19 training: mean − log10(p-value) Stabl = 5.5; mean − log10(p - value) Lasso = 5.2 . COVID-19 validation: mean − log(p-value) Stabl = 9.7; mean − log10(p-value) Lasso = 7.8 . Benchmarking of Stabl against elastic net (EN) is shown in Fig. S11 .

Journal: Research Square

Article Title: Stabl: sparse and reliable biomarker discovery in predictive modeling of high-dimensional omic data

doi: 10.21203/rs.3.rs-2609859/v1

Figure Lengend Snippet: a . Clinical case study 1: Classification of individuals with normotensive pregnancy or preeclampsia (PE) from the analysis of circulating cell-free RNA (cfRNA) sequencing data. Number of samples (n) and features (p) are indicated. b. UMAP visualization of the cfRNA transcriptomic features, node size and color are proportional to the strength of the association with the outcome calculated as the p-value in a univariate Mann-Whitney test using a −log10 scale. c . Clinical case study 2: Classification of mild vs. severe COVID-19 in two independent patient cohorts from the analysis of plasma proteomic data (Olink). d. UMAP visualization of the proteomic data. Node characteristics as in ( b ). e. Predictivity performances of Stabl and Lasso for the PE datasets. AUROC Stabl = 0.83 [0.76, 0.90] , AUROC Lasso = 0.84 [0.78, 0.90] (p-value = 0.28, Bootstrap test); AUPRC Stabl = 0.85 [0.77, 0.93] , AUPRC Lasso = 0.89 [0.83, 0.94] (p-value = 0.18) f. AUROC comparing predictive performance of Stabl and Lasso on training (left panel) and validation (right panel) cohorts for the COVID-19 dataset. Training: AUROC Stabl = 0.85 [0.74, 0.94] , AUROC Lasso = 0.86 [0.75, 0.94] (p-value = 0.37) . Validation: AUROC Stabl = 0.75 [0.71, 0.79] , AUROC Lasso = 0.76 [0.71, 0.81] (p-value = 0.44) . AUPRC are shown in Fig. S12. g-h. Left panels. Sparsity performances for the PE ( g , number of features selected across cross-validation iterations, median Stabl = 11.0, IQR = [7.8,16.0], median Lasso = 225.5, IQR = [147.5,337.5], p-value < 1e-16 ) and COVID-19 ( h, median Stabl = 7.0, IQR = [4.8,13.0], median Lasso = 19.0, IQR = [8.0,100.0], p-value = 4e-10) datasets. Right panels. Stability path graphs showing the regularization parameter against the selection frequency. The reliability threshold ( θ ), is indicated (dotted line) i-k . Volcano plots depicting the reliability performances of Stabl and Lasso for the PE ( i ), COVID-19 training ( j ) and COVID-19 validation ( k ) datasets. The maximum frequency of selection of each feature is plotted against the −log10 p-value using a univariate Mann-Whitney test. Features selected by Stabl/Lasso only are colored in red/black respectively. Features selected by Stabl are labeled. PE: mean − log10(p-value) Stabl = 8.2; mean − log10(p-value) Lasso = 3.3 . COVID-19 training: mean − log10(p-value) Stabl = 5.5; mean − log10(p - value) Lasso = 5.2 . COVID-19 validation: mean − log(p-value) Stabl = 9.7; mean − log10(p-value) Lasso = 7.8 . Benchmarking of Stabl against elastic net (EN) is shown in Fig. S11 .

Article Snippet: Because clinical omic datasets can vary greatly with respect to dimensionality, signal-to-noise ratio, and technology-specific data preprocessing, we tested Stabl on datasets representing a range of bulk and single-cell omics technologies, including RNA sequencing (RNA-Seq), high-content proteomics (SomaLogic and Olink platforms), untargeted metabolomics, and single-cell mass cytometry.

Techniques: Sequencing, MANN-WHITNEY, Clinical Proteomics, Biomarker Discovery, Selection, Labeling